Navigation Links
Cold Spring Harbor science teams identify 13 new tumor-suppressor genes in liver cancer
Date:11/18/2008

cer samples that provided a basis for the work of the combined teams. Powers' lab scanned the genomes of liver cancers from more than 100 patients to compile a list of deletions of chromosomal regions. These regions were hypothesized to be the location of most of the missing tumor suppressor genes. A comparison of this list with the genome sequence of a normal human cell revealed the identity of approximately 300 genes within the deleted chromosomal segments.

Chromosomal deletions aren't limited to cancer-related genes alone; any number of "passenger" or unrelated neighboring genes can inadvertently also be lost. The team therefore had to pinpoint the tumor suppressors among the 300 genes. "Genomic analysis of human tumors is important," Powers observed," but combining it with functional screening in mouse models is a notable step forward."

The usual route of characterizing a gene's function is to mutate it in mouse embryos and then create lines of mice that can then be examined for the mutation's effects. Lowe's group bypassed this step, which is time-consuming, by engineering mutations into the genome of adult mouse cells and then re-injecting these cells into adult mice. The team used a method honed by Dr. Hannon of introducing stable mutations into mouse cells via RNA interference, or RNAi, a technique in which small RNA molecules are introduced into cells to shut off specific genes.

RNA sequences that corresponded to all the 300 or so deleted genes were obtained from an RNAi "library" compiled by the Hannon lab. Lowe's team introduced these RNAi tools (known as "short-hairpin RNAs, or shRNAs) into progenitor cells that develop into mature liver cells, albeit ones engineered to over-produce a cancer gene product called Myc.

In cells with these Myc mutations, an additional "trigger" such as the shutting off of a tumor suppressor gene via RNAi would be sufficient to cause cancer. The engineered cells that carried a Myc mut
'/>"/>

Contact: Hema Bashyam
bashyam@cshl.edu
516-367-6822
Cold Spring Harbor Laboratory
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Canola Oil Consumed During Pregnancy Lowers Breast Cancer Risk for Offspring
2. Susan G. Komen for the Cure(R) Hosts Inaugural Illinois State Summit in Springfield
3. This Thanksgiving Season, Lifespring Health is Helping You Donate While You Shop
4. Springer launches Cognitive Computation
5. WellSpring Pharmaceutical Corp. Names Wendy Shusko as New Chief Operating Officer
6. Springer adds Journal of Neurodevelopmental Disorders to biomedical journal portfolio
7. WellSpring Pharmaceutical Corp. Acquires Consumer Product Brands from McNeil Consumer Healthcare -- Deal Enhances US and Canadian Pharmaceutical Business
8. The Health Insurance Advocate Radio Show Expands to Springfield, Missouri, and Reaches a New All-Time Ratings High for Female Listenership
9. Insomnia in parents can result in sleep problems, suicidal behavior among their offspring
10. HMS Holdings Corp. to Present at Stephens 2008 Spring Investment Conference
11. The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:MIT's McGovern Institute researchers awarded $8.5M to study brain basis of autism and dyslexia 2Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 2Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 3Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 4Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 5Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 6Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 7Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 8Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 9Health News:AmeriHealth Mercy Family of Companies Acquires Community Behavioral HealthCare Network of Pennsylvania 2Health News:Psychotherapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars 2Health News:AMERIGROUP Foundation Announces Winners of 'Word About Health' Contest 2Health News:MUSC's Hollings Cancer Center, Ralph H. Johnson VA Medical Center Partner on New TomoTherapy Treatment for Cancer Patients 2
Breaking Medicine Technology:Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 2Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 3Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 4Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 2Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 3Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 4CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan 55054 1InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan 55054 2InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan 55054 3InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan 55054 4Cell Therapeutics Inc Announces Closing of Registered Offering of 2430 Million of Preferred Stock and Warrants 13648 1Cell Therapeutics Inc Announces Closing of Registered Offering of 2430 Million of Preferred Stock and Warrants 13648 2DS Waters of America Inc Partners With Susan G Komen for the Cure 28R 29 55050 1DS Waters of America Inc Partners With Susan G Komen for the Cure 28R 29 55050 2DS Waters of America Inc Partners With Susan G Komen for the Cure 28R 29 55050 3DS Waters of America Inc Partners With Susan G Komen for the Cure 28R 29 55050 4